Position in GILD
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$258,997
-$26,711 QoQ
Shares Held
2,050
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#1,762
of 2,266 holders
Holding Since
Sep 2020
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SEARLE & CO. holds $43,484,840 across 9 Drug Manufacturers - General names. GILD ranks #9 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
49,202 | $12,381,191 | |
| 2 | JNJ |
Johnson & Johnson
|
39,252 | $9,968,830 | |
| 3 | MRK |
Merck & Co., Inc.
|
54,913 | $7,056,320 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
79,700 | $4,592,314 | |
| 5 | LLY |
ELI LILLY & Co
|
3,530 | $4,233,988 | |
| 6 | AMGN |
Amgen Inc
|
6,771 | $2,451,914 | |
| 7 | PFE |
Pfizer Inc
|
88,705 | $2,136,016 | |
| 8 | SNY |
Sanofi
|
9,500 | $405,270 |
All Filings in GILD
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $258,997 | 2,050 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $285,708 | 2,050 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $251,617 | 2,050 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $227,550 | 2,050 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $227,283 | 2,050 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $229,702 | 2,050 | Shares | Sole | 2025-05-15 | |
| 2024-06-30 | $463,117 | 6,750 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $296,662 | 4,050 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $328,090 | 4,050 | Shares | Sole | 2024-02-06 | |
| 2020-12-31 | $320,430 | 5,500 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $265,398 | 4,200 | Shares | Sole | 2020-10-30 | |
| No filing history on record for this holder in this stock. | ||||||